Effect of renal function on the pharmacodynamics of argatroban.
about
Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.Heparin-induced thrombocytopenia: treatment options and special considerations.Essentials of anticoagulation in hemodialysis.Argatroban anticoagulation in critically ill patients.Impact of renal function on argatroban therapy during percutaneous coronary intervention.Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.Argatroban in the management of heparin-induced thrombocytopenia.Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation.Anticoagulation Therapy in Patients with Chronic Kidney Disease.Monitoring of Argatroban and Lepirudin.Considerations for analgosedation and antithrombotic management during extracorporeal life support.
P2860
Q33366226-D500664B-D808-4121-AC70-73B52129B55EQ33374658-3B9D5AB9-3E23-4ACA-BF0D-DFAD7FC443E9Q33374743-379A3E26-D95B-4FCF-BF04-E4BF0396829DQ33374919-7CC40BFD-804F-4189-BB1C-3B3719C3015FQ33384889-6E01956E-8E17-479B-A924-08252EA3CD09Q33385916-0A1B70D3-CAB2-4E64-A7FA-E7B1860CC3D9Q33385970-B534B365-945B-40C8-BEAA-EB6DF6D53255Q33389707-ACF89445-1DB9-48ED-83FD-ADCA019506F6Q33391969-C8F3FE98-9AC9-420F-8CD7-C13D0F953B3EQ33393015-A2D88FC9-F989-449E-A89F-3424B1D89C7BQ33400597-9EF64381-F841-45CC-9D71-6725CC57C699Q33403844-B46930B1-79E8-46D4-A22F-076E92616B99Q33407767-7C5D6FCC-DD26-443D-8D6E-FA0CDBA23187Q33435357-4B497FE9-2E1D-4876-93A5-599457993693Q33440268-742A21FA-5901-4F19-8A79-B803B1A59AD6Q39169651-827EBE14-094C-4D7E-81E2-D990E6A8327F
P2860
Effect of renal function on the pharmacodynamics of argatroban.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Effect of renal function on the pharmacodynamics of argatroban.
@ast
Effect of renal function on the pharmacodynamics of argatroban.
@en
type
label
Effect of renal function on the pharmacodynamics of argatroban.
@ast
Effect of renal function on the pharmacodynamics of argatroban.
@en
prefLabel
Effect of renal function on the pharmacodynamics of argatroban.
@ast
Effect of renal function on the pharmacodynamics of argatroban.
@en
P2860
P356
P1476
Effect of renal function on the pharmacodynamics of argatroban.
@en
P2093
Paul A Arpino
Robert K Hallisey
P2860
P356
10.1345/APH.1D163
P407
P577
2004-01-01T00:00:00Z